Clinical trial · Observational
Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment
NCT01888198CI-TRIAL-00116703active not recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to better understand how effective ablation is for destroying tumor cells in the kidney and whether quality of life is improved for patients. Participation in ARMOR may involve retrospective data collection only, combined retrospective and prospective data collection, or prospective data collection
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Renal Cancer | Kidney Neoplasm | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| (EORTC QLQ-C30) questionnaire | Behavioral | — | UNRESOLVED |
| EuroQol EQ-5D 7-item questionnaire | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- renal mass ablation candidates
- description
- Standard of care interventions for the treatment of renal masses using energy ablation will be studied. Data collection can be divided into five basic categories: 1) Patient demographics and relevant history, 2) Renal mass characteristics, 3) Ablation procedure details, 4) Imaging studies, and 5) Patient-reported quality of life.
- interventionNames
- Behavioral: (EORTC QLQ-C30) questionnaire
- Behavioral: EuroQol EQ-5D 7-item questionnaire
Primary outcomes (1)
- measure
- assess renal ablation outcomes
- timeFrame
- 5 years
- description
- To assess renal ablation outcomes using standard quality of life measures. Specifically, quality of life outcomes measures will be analyzed with respect to ablation procedure characteristics including ablation technique and anesthesia type as well as renal mass characteristics such as size, location and pathologic tumor type.
Secondary outcomes (3)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: Retrospective enrollment: \- Patients having undergone percutaneous, open or laparoscopic energy ablation of a renal mass. Prospective enrollment: \- Patients scheduled to undergo, rather than having undergone, percutaneous, open or laparoscopic energy ablation of a renal mass. Exclusion Criteria: * Patients not having undergone, or considered candidates for percutaneous, open or laparoscopic energy ablation of a renal mass * Non-English speaking patients * Patients under the age of 18.
References
Publications (0)
Data not yet available
No reference posted for this study.